HRT Myths Debunked: Facts for Women Considering Hormone Therapy

Many common HRT myths overlook an important fact: hormone replacement therapy is not automatically safe or unsafe for every woman. The potential benefits and risks depend on factors such as age, symptoms, medical history, and the type of hormone therapy used. Women in Louisiana and Mississippi who are considering HRT can use these facts to prepare for an informed conversation with their healthcare provider.

At Rejuvime Medical, we talk with women throughout Louisiana and Mississippi who are navigating perimenopause and menopause and have questions about hormone therapy. Some of the most common questions we hear include: Does HRT cause cancer? Is hormone therapy only for severe symptoms? Is it too late to start HRT? Are all hormone therapies the same?

What Are the Most Common HRT Myths?

The most common HRT myths involve cancer risk, cardiovascular health, hormone testing, bioidentical hormones, and whether hormone therapy is appropriate for every woman. Many of these concerns stem from older research or from treating all forms of hormone therapy as though they have identical risks and benefits.

“Hormone replacement therapy is not a one-size-fits-all approach. Every woman’s needs are unique, and decisions should be based on her symptoms, medical history, individual risk factors, and personal goals. My role is to educate and guide each patient through her options so we can develop a personalized treatment plan together that supports her health, well-being, and quality of life.” -Lacee May, FNP-C

Does HRT Always Increase the Risk of Breast Cancer?

No, HRT does not increase breast cancer risk equally for every woman. Risk depends on the type of hormone therapy, how long it is used, and individual medical history.

Many women associate hormone replacement therapy (HRT) with breast cancer, largely because of concerns raised by the Women’s Health Initiative (WHI) study in the early 2000s. Since then, further research has given us a more nuanced understanding of hormone therapy and the risks it may carry.

An important point is that the WHI findings should neither be dismissed nor applied indiscriminately to every modern HRT regimen. The original trials mainly studied oral conjugated equine estrogen, given with or without medroxyprogesterone acetate. Results from those specific regimens can’t automatically tell us the exact risk for every estradiol patch, gel, oral estradiol product, or progesterone formulation currently in use.

At the same time, the evidence for newer formulations isn’t equally strong across all long-term outcomes. Some risks are better understood than others, so while modern options may differ from those studied in the WHI, that difference shouldn’t be taken as proof of safety across the board.

For example, estrogen-only therapy and combined estrogen-progestogen therapy do not have identical risk profiles. Women who still have a uterus generally need a progestogen with systemic estrogen to help protect the uterine lining.

For more information about one specific form of hormone therapy, read our guide to oral estrogen therapy and hormone therapy risks.

Is HRT Too Dangerous Because of Heart Attack and Stroke Risks?

No, HRT is not automatically too dangerous for every woman. The potential risks and benefits depend on age, health history, timing of treatment, and the type and route of hormone therapy.

Hormone therapy can carry risks, including blood clots and stroke, and some risks may be higher with certain forms of treatment. At the same time, age and underlying health conditions can significantly affect an individual's risk profile.

The timing of HRT also matters. For many healthy women who are under 60 or within 10 years of menopause, the benefits of hormone therapy for bothersome menopause symptoms may outweigh the risks. These two criteria are alternatives rather than requirements that must both be met, so a woman may fall within this favorable window either by her age or by the time since her menopause.

It’s also worth noting that starting HRT is different from continuing it. Women who began treatment earlier don’t automatically need to stop at 60 or 65. Instead, whether to continue should be decided on an individual basis, with the decision revisited periodically.

That does not mean HRT is appropriate for every woman. It means the decision should be individualized instead of based on the assumption that hormone therapy carries the same risk for everyone.

Is HRT Only for Women With Severe Menopause Symptoms?

No, HRT is not limited to women with severe menopause symptoms because hormone therapy may be considered when menopause symptoms are bothersome enough to affect your quality of life.

Hot flashes and night sweats are among the symptoms most effectively treated with systemic hormone therapy. Hormone therapy may also help with other menopause-related concerns, including vaginal symptoms and sleep disruption.

Some women experience relatively mild symptoms while others find that menopause affects their sleep, energy, sexual wellness, work, exercise, or day-to-day activities.

For more information about how menopause can affect women differently, explore our menopause and female aging treatment options.

Is It Too Late to Start HRT After Menopause Begins?

No, reaching menopause does not automatically mean you are too late to discuss hormone therapy because the potential benefits and risks of HRT depend partly on when treatment begins.

However, being older or further from the beginning of menopause does not mean you should automatically start or automatically avoid HRT. Your provider should consider your symptoms, medical history, cardiovascular health, cancer history, and other risk factors before recommending treatment.

Does Everyone Need Hormone Testing Before Starting HRT?

No, hormone testing isn’t always necessary before starting HRT. Many women can be evaluated based on their symptoms, age, menstrual history, and overall health, without the need for blood tests to confirm menopause.

That said, while labs aren’t required, they can still be useful. Testing may help identify other conditions that could be causing or contributing to symptoms, ensuring that the right issue is being treated.

Hormone levels can fluctuate during perimenopause, so a single test may not reflect those changes over time. Your provider can determine whether laboratory testing is appropriate based on your symptoms and medical history.

At Rejuvime Medical, our approach to hormone care includes reviewing your individual health information and determining what evaluation is appropriate for your situation. The goal is to understand the full picture rather than relying on symptoms or a single test alone.

Are Bioidentical Hormones Automatically Safer Than Other HRT?

No, bioidentical hormones are not automatically safer or more effective than other forms of hormone therapy simply because they are described as bioidentical.

Bioidentical hormones are designed to be chemically similar or identical to hormones produced by the body. Some bioidentical hormones are FDA-approved medications, while others are compounded preparations.

The distinction matters because compounded hormone products are not evaluated by the FDA in the same way as FDA-approved medications. Women considering HRT should ask what type of hormone is being recommended, why it is being recommended, and how the treatment will be monitored.

What Should Women Know Before Starting HRT?

Women considering HRT should consider their symptoms, health history, family history, and individual risk factors before deciding whether hormone therapy is appropriate.

A conversation with a qualified medical provider can help you understand:

• Which menopause symptoms you want to address
• Whether hormone therapy is appropriate for your situation
• Which type of hormone therapy may be appropriate
• Whether you have risk factors that could affect treatment
• Which potential benefits and risks apply to you
• How your treatment should be monitored over time

Certain women may not be good candidates for systemic hormone therapy, including women with certain histories of breast or endometrial cancer, stroke, heart attack, blood clots, or liver disease.

Your provider can help determine whether HRT is appropriate or whether another approach may better address your symptoms.

How Can Women in Louisiana and Mississippi Learn More About HRT?

Women in Louisiana and Mississippi who are considering HRT can meet with a Rejuvime Medical provider to discuss their symptoms, health history, and whether hormone therapy may be appropriate for their individual needs.

Rejuvime Medical provides individualized hormone care for women experiencing perimenopause and menopause at locations throughout Louisiana and Mississippi. Our providers consider your symptoms, health history, treatment goals, and potential risks when discussing your options.

If you have been hesitant about HRT because of something you read online, you do not have to make a decision based on fear or outdated information. Get the facts, understand your individual risks and potential benefits, and have an informed conversation with a qualified provider.

Ready to learn whether HRT may be right for you? Explore hormone replacement therapy at Rejuvime Medical or request a consultation at a Rejuvime Medical location in Louisiana or Mississippi.